Fig. 5: Fas-L-treated P3 ASCs and Fas-L-treated SVF cells (P0 ASCs) display a similar phenotype. | Cell Death & Disease

Fig. 5: Fas-L-treated P3 ASCs and Fas-L-treated SVF cells (P0 ASCs) display a similar phenotype.

From: Fas-L promotes the stem cell potency of adipose-derived mesenchymal cells

Fig. 5

ASCs (P3) were cultured for 6 days under normal culture conditions or with increasing Fas-L concentrations. Cell numbers (aI) and sub-G1 proportions aII and b were examined by standard cell counts and by propidium iodide (PI) cell cycle flow cytometry analysis, respectively. The experiment was repeated three times using cells from three independent patients. Data are presented as the mean ± standard deviation. P3 ASCs cultured under normal culture conditions or with 50 ng/ml Fas-L, surface marker expression of CD29, CD105, and CD73 was examined by flow cytometry (c)

Back to article page